Interventional Neurology Devices - Global Market Outlook (2017-2023)
According Stratistics MRC, the Global Interventional Neurology Devices Market is accounted for $1.89 billion in 2016 and expected tgrow at a CAGR of 10.3% treach $3.76 billion by 2023. The market factors such as growth due tobesity and aged population, rising frequency for hemorrhagic and ischemic stroke, ongoing product development and commercialization, expansion of healthcare infrastructure across emerging markets are propelling the market growth. However, stringent regulations and lack of talented neurologists are restraining the market growth. Increasing research activities in the field of neurovascular therapies, demand for minimally invasive neurosurgical procedures and surgeon’s awareness related tbenefits of stereotactic framework procedures in neurosurgeries are creating wider opportunities for the market growth.
Cerebral arteriovenous malformations and dural arteriovenous fistulas (DAVFs) require complex treatment. The endovascular treatment with embolization is a fundamental component of the multidisciplinary management, together with radiosurgery and surgery. Microsurgery (ie, craniotomy followed by resection) has been reported thave a low risk of complications for in SMG I and II brain AVMs. Ischaemic strokes are caused by a blockage cutting off the blood supply tthe brain. The blockage can be caused by a blood clot forming in an artery leading tthe brain or within one of the small vessels deep inside the brain. Trials namely the ESCAPE, SWIFT PRIME, and EXTEND-IA studies alsproved the effectiveness of mechanical thrombectomy in large vessel occlusion.
At present, Food and Drug Administration (FDA) approved the Pipeline embolization device (PED; Medtronic) for use in anterior circulation aneurysms. Presently, PED and its second generation, the Pipeline Flex, are the only flow diverters available in the United States. Internationally, the Silk device (Balt Extrusion), p64 flow modulation device (phenox GmbH), Flow Re-direction Endoluminal Device (FRED; MicroVention Terumo), and Surpass device (Stryker) are available. New coils, both pushable and detachable, have alsrecently been developed. The use of detachable coils with different lengths and volumes is on the rise, and a new coil without a metallic frame has alsarrived tthe market. The use of liquid embolic materials is increasing in peripheral applications. New materials are in the pipeline. For example, Squid is a non adhesive liquid embolic agent for embolization of brain Arteriovenous Malformations (AVM). It is composed of EVOH (ethylene vinyl alcohol copolymer) with suspended micronized Tantalum powder for radiopacity and DMSO (dimethyl sulfoxide) solvent. Squid must be injected through a DMSO compatible microcatheter.
Recently clot retrieval devices were approved by the FDA as first-line treatment along with IV rt-PA. The Penumbra Aspiration System, EmboTrap(®)II, stent retrievers, have the FDA clearance as first-line treatment for acute ischemic stroke along with IV rt-PA. Neurothrombectomy devices offer many potential advantages over pharmacologic thrombolysis, including more rapid achievement of recanalization, enhanced efficacy in treating large-vessel occlusions, and a potentially lower risk for hemorrhagic events. Currently, twneurothrombectomy devices are cleared by the U.S. Food and Drug Administration (FDA) through its 510(k) process: the MERCI Retriever (Concentric Medical) and the Penumbra System.
North America is expected tdominate the market owing tadoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials and significant medical reimbursement available in the U.S. for neurosurgical procedures.
The key players in Global Interventional Neurology Devices market are Abbott, Medtronic, Stryker, TERUMO, Acandis, B. Braun Melsungen, Bayer, Boston Scientific, Biosensors International, Covidien PLC, Integra LifeSciences Holdings Corporation, St. Jude Medical, Inc, W.L. Gore & Associates, Inc. and Magstim CLtd.
• Arteriovenous Malformation and Fistulas
• Cerebral Aneurysms
• Schemic Strokes
• Intracranial Atherosclerotic Disease
• Carotid Artery Angioplasty and Stenting
Carotid Artery Stents
Embolic Protection Systems
Balloon Occlusion Devices
• Aneurysm Coiling and Embolization Devices
Flow Diversion Devices
Liquid Embolic Devices
• MicrSupport Devices
Suction and Aspiration Devices
Clot Retrieval Devices
• Angioplasty & Stenting
• Pre-operative Tumor Embolization
• Stroke Therapy
End Users Covered:
• Ambulatory Care Centers
• Neurology Clinics
• North America
Rest of Europe
• Asia Pacific
Rest of Asia Pacific
• South America
Rest of South America
• Middle East & Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements